{"nct_id":"NCT03478787","title":"Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis","status":"COMPLETED","status_verified_date":"2021-06","start_date":"2018-05-08","start_date_type":"ACTUAL","primary_completion_date":"2020-07-08","primary_completion_date_type":"ACTUAL","completion_date":"2020-07-08","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}